Mallinckrodt Presents Information on TERLIVAZ ® (terlipressin) for Injection in Sufferers with Hepatorenal Syndrome (HRS) at Kidney Week 2024 By Investing.com
“ Pooled evaluation from Part 3 scientific trials highlights liver transplant charges…
Mallinckrodt to promote Therakos unit to CVC for $925 million By Investing.com
DUBLIN and LUXEMBOURG - Specialty pharmaceutical firm Mallinckrodt plc (OTC:) has agreed…
